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Notch in Invertebrate Development.
 
Notch proteins are
highly conserved transmembrane receptors that are in-
volved in cell fate regulation in invertebrates (1). While
Notch receptors are initially synthesized as single polypep-
tide chains proteolytic processing results in the formation
of a heterodimeric receptor in which the extracellular do-
main is noncovalently attached to the transmembrane and
intracellular (IC) part. The Notch-IC is responsible for sig-
naling and contains a series of ankyrin repeats similar to
 
those found in nuclear factor (NF)-
 
 
 
B. The ligand-depen-
dent release of Notch-IC requires processing by the mem-
brane-associated presenilin which in a mutant form is re-
sponsible for familial Alzheimer’s disease. The biochemical
pathway of Notch-IC dissociation from the receptor is not
completely understood but requires at some stage pro-
teolytic cleavage (Fig. 1).
The Notch receptor ligands include Delta, a transmem-
brane protein that affects adjacent cells expressing Notch
receptors (2), but may also interact with Notch receptors
expressed by the very same cell. Also, soluble Delta ligands
have been reported the action of which, however, appears
restricted to immediately neighboring cells.
 
The detailed biochemical events that lead to the disso-
 
ciation of Notch-IC from the heterodimeric Notch
 
receptor after ligation are still unknown. There is also
relatively little known of how Notch-IC regulates tran-
scriptional activity: Notch-IC contains conserved nuclear
localization sequences. However, Notch-IC may not di-
rectly enter the nucleus but may form a complex with the
suppressor of hairless (Su(H)) protein which may function
as a transcriptional regulator. Alternatively this complex
may allow further posttranslational modifications. What
appears to be clear is that only tiny amounts of Notch-IC
reach the nucleus.
One of the more often discussed modes of Notch activ-
ity consists of so-called lateral signaling whereby appar-
ently stochastic small differences of Notch receptors and
Delta ligands on apparently otherwise equivalent neigh-
boring cells are exaggerated by feedback loops resulting in
cells that either express high levels of Notch receptors or
high levels of Delta ligands. Again the biochemistry of
these feedback loops is poorly understood. The important
point is that the cells with high levels of Notch or high
levels of Delta assume different developmental fates (2).
However, there are clearly also interactions between
Notch receptors and ligands on nonequivalent cells i.e.,
cells in which the developmental potential differs before
the receptor-ligand interaction.
 
Notch in the Mammalian System.
 
In mammals four dif-
ferent Notch receptors (Notch 1–4) and four different
ligands (Jagged-1 and -2 as well as Delta-like 1 and 3) have
been identified. Expression of Notch receptors and ligands
is found in lymphoid tissue including bone marrow and
thymus (3). The intracellular signaling pathways involve
the association of Notch-IC with the mammalian equiva-
lent of Su(H), CBF-1. CBF-1 is present in most mamma-
lian cells and in the absence of the Notch functions as a
transcriptional repressor. The association with Notch-IC
may convert this function into a transcriptional activator,
again by largely unknown biochemical events. Notch-IC
binds also to the intracellular zinc finger protein Deltex
which does not translocate to the nucleus. The formation
of the CBF-1 Notch-IC and Deltex Notch-IC complexes
may have different consequences, the former resulting in
the activation of NF-
 
 
 
B and a family of basic helix loop
helix (bHLH) proteins named Hairy Enhancer of Split
(HES-I) whereas the latter may result in the repression of
another bHLH protein E47. Both HES-I and E47 have
important functions in the immune system (1; Fig. 1).
 
Notch in the Immune System.
 
Initial studies on a putative
role of Notch-1 in determining T cell fate in the mamma-
lian immune system involved transgenic overexpression of
Notch-IC that was associated with an increased ratio of
CD8 over CD4 single-positive (SP) thymocytes (4), the
commitment of which is controlled by the specificity of
the 
 
 
 
,
 
 
 
TCR for class I and class II MHC molecules, re-
spectively (5). Such an effect was not apparent with a dif-
ferent transgenic Notch-IC construct that increased sur-
vival of immature thymocytes (6). The physiological
relevance of these observations is not clear for several rea-
 
sons: first, the increased number of SP CD8
 
 
 
 thymocytes
included abnormal cells that did not leave the thymus (4).
Second, conditional inactivation of a floxed Notch-1 gene
by the Cre-recombinase under control of a CD4 promoter
failed to reveal any essential role of Notch-1 in the survival
and ratio of SP CD8 and CD4 cells (7). These apparently
contradictory results are consistent either with Notch re-
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dundancy or transgenic artifacts of unphysiological overex-
pression. Third, the Notch-1 transgenic mice developed
regularly tumors (4, 6) implying an unphysiological func-
tion of the transgene.
Analysis of loss and gain of Notch activity was, however,
quite complementary at an earlier time in lymphoid devel-
opment, namely the commitment of precursors to either
the B or T cell lineage. An early report on the loss of func-
tion of the floxed Notch-1 gene by the Cre-recombinase
under the control of the regulatable MX-promoter re-
vealed a complete block in T cell development starting at
the earliest double negative (DNI) activity precursors in the
thymus (8). Subsequent reports on loss or gain of Notch-1
function, which are discussed in the following, significantly
contribute to our understanding of T and B cell commit-
ment in early precursors in the bone marrow or thymus as
well as to the understanding of the mechanisms involved in
the generation of acute T cell leukemias (9–12).
 
Instruction of T Cell Commitment by Notch.
 
Recent
studies by Wilson et al. (9) on the ablation of Notch-1 in
adult mice are best compatible with the view that nor-
mally Notch-1 instructs T cell lineage commitment and
that in its absence B cell development takes over: after in-
activation of Notch-1 in lymphoid precursors the DN 1,
2, and 3 thymocyte subsets were rapidly diminished and
in the thymus a concomitant increase in B cell precursors
was observed. As B cell precursors were not detected in
Figure 1. Regulation of transcription by Notch-1. Following
binding of the Delta-like ligand, the Notch-IC part of the Notch-1
receptor is released, interacts with CBF-1, and regulates transcrip-
tion. Binding of Notch-IC to the Deltex-ligand regulates tran-
scription by a different pathway.
Figure 2. Hypothetical scheme of T versus B lineage commitment.
When common lymphoid precursors (CLP) encounter the Notch-1
ligand Delta-like-1 in the thymus or fetal liver they become T committed
precursors at the expense of B committed precursors. In the absence of
Delta-like-1 ligands B cell development predominates. 
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the blood and B cells were generated after intrathymic in-
jection of Notch-1
 
 
 
/
 
 
 
 bone marrow, the authors con-
cluded that B cell precursors did not migrate into the thy-
mus but that instead of T cells B cells were much more
efficiently produced from precursors in the thymus. Simi-
larly, the ectopic expression of lunatic fringe, a modifier
of Notch-1 signaling, in thymocytes caused in a non-cell-
autonomous fashion the intrathymic development of B
cells (10).
These analyses of loss of Notch-1 activity in the thymus
are supported by studies on gain of Notch-1 activity in the
bone marrow (11): a Notch-IC transgene blocked B cell
differentiation in bone marrow while permitting the accu-
mulation of CD4
 
 
 
CD8
 
 
 
 lymphoid cells in bone marrow
and spleen. In pre-TCR–deficient mice (i.e., RAG
 
 
 
/
 
 
 
,
TCR
 
 
 
 
 
/
 
 
 
, or SLP 76
 
 
 
/
 
 
 
 mice) the Notch-IC transgene
resulted only in the accumulation of cells with the pheno-
type of DN2 and DN3 thymocytes arguing that Notch-IC
could not replace pre-TCR function (11, 13) but increased
the number of T cell precursors before the onset of TCR
rearrangement. These cells expressed in addition to the
CD44/25 surface markers CD3
 
 
 
 and pT
 
 
 
 at the RNA
level. The authors interpreted these results to indicate that a
Notch-IC transgene instructs T cell development in the
bone marrow at the expense of B cell precursors, perhaps
by inducing commitment to the T lineage in a common
lymphoid precursor (11, 14). This possibility is consistent
with a third study on Notch-1 activity (12) which analyzes
the impact of expression by either Jagged-1 or Delta-like-1
ligands by murine stromal cells on the differentiation of hu-
man CD34-positive cells in an in vitro culture system: B
cell development was blocked by Delta-like-1 but not
Jagged-1 ligands in spite of the fact that both ligands were
expressed in a functionally meaningful fashion. In addition,
the authors observed that Delta-like-1 ligands on stromal
cells permitted the accumulation of cells with characteris-
tics of early T cells.
While none of the three studies directly addresses the
question whether Notch-IC or Notch-ligands affect a
common lymphoid precursor, the quantitative aspects as
reported by Wilson et al. (9) and Allman et al. (11) are con-
sistent with this idea while Jaleco et al. are careful in point-
ing out (12) that Notch may not necessarily instruct com-
mitment in a common precursor but may arrest B cell
committed precursors while allowing differentiation of T
cell committed precursors. Thus there is still opportunity
for more definitive experiments.
Notch-induced T lineage commitment may be achieved
by the Notch-IC-Deltex complex dependent repression of
the E box binding E47 protein, E47 being required for B
lymphopoiesis (15). However, as pointed out (11) E2A ac-
tivity appears to be required also at early stages in T cell de-
velopment. Additionally, Notch-1 may activate through
binding to CBF-1 another member of the bHLH proteins,
the HESI that plays a critical role in the expansion of early
T cell precursors (16). More detailed studies are required to
define the mechanisms by which Notch-1 activity favors
the T cell lineage.
At present a scenario can be envisaged where the absence
of inductive signaling by Notch-1 in the thymus through
Delta-like-1 ligation leads to the adoption of B cell fate by
common lymphoid precursors whereas Delta-like-1–
dependent Notch-1 activation diverts these precursors to
the T cell lineage Delta-like-1 ligands may normally be
only poorly expressed in the bone marrow (12) such that
no T cell committed precursors could be formed outside
the thymus in the adult organism. In fetal liver, however,
T cell committed precursors have been described (16) and
perhaps Delta-like 1 ligands are expressed there (Fig. 2).
 
Cooperation of Notch and the Pre-TCR in Acute Leuke-
mia.
 
Notch may induce T cell fate through HES-1 acti-
vation. It has also been reported that overexpressed Notch-
IC enhances pre-TCR expression (6). It is clear, however,
from the data reported in (10, 12) that overexpressed
Notch-1 cannot replace pre-TCR function even though it
may activate NF-
 
 
 
B to some extent (1).
It has perhaps not been sufficiently stressed that to date
all mice harboring Notch-IC transgenes develop regularly
tumors that exhibit markers of immature thymocytes. Such
acute leukemia-like tumors can be generated through
Notch-1 (4, 6, 17, 18) and Notch 3 transgenes (19) and re-
quire in all cases a functional pre-TCR (reference 10, and
Screpanti, personal communication). It has been established
that constitutive pre-TCR signaling, independent of any
putative ligands on thymic stroma results in NF-
 
 
 
B activa-
tion (20) that may at least in part be responsible for anti-
apoptotic as well as proliferation signals at the pre-TCR
controlled checkpoint. Overexpressed Notch-IC may in-
fluence transformation in several ways: it may continually
upregulate the pre-TCR and thus be responsible for con-
tinuous pre-TCR signals. It may also synergize with pre-
TCR signals through direct activation of antiapoptotic
pathways as well as NF-
 
 
 
B (1). Finally, pre-TCR signals
may set the stage for Notch-induced transformation. It is
not clear, at present, whether some translocation event re-
sults in Notch activation in these tumors. The fact, how-
ever, that Notch and the pre-TCR cooperate both in de-
velopmental progression and tumorigenesis (references 11
and 19, and Screpanti, personal communication) makes
Notch and pT
 
 
 
 possible targets for tumor therapy.
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